Clinical trial
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With…
NCT00007982 · Herbert Irving Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00007982 |
|---|---|
| Title | Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer |
| Official title | CAMP 004A - Phase 2 Study Of Intensive Chemotherapy (BET) For Selected Categories Of Malignant Central Nervous System Tumor |
| Lead sponsor | Herbert Irving Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Head and Neck Cancer, Lymphoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carmustine, cisplatin, cyclophosphamide, etoposide, thiotepa, adjuvant therapy, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Enrollment | 30 |
| Start date | Apr 1, 1999 |
| Primary completion | Feb 1, 2005 |
| Completion | May 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: